ArticleBMC medicine2025
Long-term accrual of conditions following myocardial infarction: a study of disease trajectories in the Wales Multimorbidity e-Cohort.
Article in BMC medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundImproved survivorship following myocardial infarction (MI) has resulted in transferred morbidity to other long-term conditions (LTCs). Understanding of disease accrual over time following MI has been limited by a lack of methodologies that consider real-world complexity. We characterised post-MI multimorbidity trajectories in a real-world population of individuals following MI.
methodsThis population-wide retrospective study comprised all individuals with MI in the Wales Multimorbidity e-Cohort (which included linked primary and secondary care data for 2,902,101 GP-registered residents of Wales; 2005-2019). Single-year post-MI disease clusters and multi-year latent multimorbidity trajectories were constructed from 227 chronic conditions and 62 acute conditions, using non-negative matrix factorisation (NMF). Multinomial logistic regression identified sociodemographic factors associated with single-year post-MI disease clusters. Time-updating flexible parametric survival models quantified the association between multi-year multimorbidity trajectories and long-term all-cause mortality, adjusting for age, sex, year of MI, socioeconomic deprivation and rurality.
resultsIn total, 70,529 individuals had an incident MI during the study period (median [interquartile range] age 72 [62-82] years; 40.6% female), with restricted mean post-MI survival of 8.1 years. At MI diagnosis, 67,023 (95.0%) had ≥ 2 LTCs (median 8 [interquartile range; IQR 5-12]), which increased to 99.8% at 1 year (50,633/50,737 surviving patients, median [IQR] 12 [7-17]). NMF classified individuals into one of 10 post-MI disease clusters, based on all observed acute and chronic diagnoses (n = 3,954,622) accrued over time. Individuals that followed the most adverse latent multimorbidity trajectory (n = 26,035, 36.9%) were characterised by recurrent MI, acute infections and renal disease and had an increased risk of all-cause mortality (adjusted hazard ratio 6.62; 95% CI: 6.09-7.20) compared with individuals in the least adverse trajectory.
conclusionsPatients with MI have a high pre-existing multimorbidity burden that increases post-MI. Using NMF, we were able to reduce the real-world complexity of all individual diseases accrued over time into 10 latent post-MI multimorbidity trajectories. These trajectories were characterised by specific patterns of acute and chronic conditions, with differential impact on outcomes. These trajectories may enable the implementation of targeted strategies for individuals that are at greatest risk of adverse outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.